REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/05/2025
Back to search
Official data from USPTO
MATT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/06/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/31/2019
Registration date
05/05/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2020
Last transaction
05/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
ADEMI, XHENETA
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Orthocell Limited
Representatives
Matthew J. Stark Price Heneveld LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Stem cells for medical purposes; medical preparations for use in connection with the regeneration of bone and soft tissue; guided tissue regeneration materials, namely, medical preparations for use in connection with the regeneration of bone and soft tissue; biological preparations for medical purposes, namely, for the regeneration of bone and soft tissue; tissue-regenerative medical preparations, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of tissues for medical use, namely, for use in connection with the regeneration of bone and soft tissue; surgical implants grown from stem cells comprised of living tissues for use in connection with the regeneration of bone and soft tissue; collagen for medical use; medical preparations in the nature of biodegradable implants for use in guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implant materials for use in guided tissue regeneration in surgery, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implantable materials for use in guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implants for guided tissue regeneration, namely, for use in connection with the regeneration of bone and soft tissue; therapeutic agents for medical purposes, namely, for the regeneration of bone and soft tissue; therapeutic biological tissue cultures for medical purposes, namely, for the regeneration of bone and soft tissue
Class 42
Medical research; scientific research and technological research services; scientific research relating to biology; all the foregoing in the field of the regeneration of bone and soft tissue and biomechanical and cellular therapeutic medical techniques
Class 44
Advisory services relating to medical services; physical therapy; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical therapy services; all the foregoing in the field of the regeneration of bone and soft tissue and biomechanical and cellular therapeutic medical techniques, namely, all related to the provision of therapies involving the surgical implantation of cellular scaffold matrices
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/10/2020
FIMP
FINAL DISPOSITION PROCESSED
09/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2020
ALIE
ASSIGNED TO LIE
01/14/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
01/10/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/10/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
01/10/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/08/2019
RFNT
REFUSAL PROCESSED BY IB
06/01/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/11/2019
RFRR
REFUSAL PROCESSED BY MPU
05/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/19/2019
CNRT
NON-FINAL ACTION WRITTEN
04/18/2019
DOCK
ASSIGNED TO EXAMINER
04/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/23/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/19/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/14/2019
Continuous trademark protection
Get notified about every new filing that threatens MATT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.